Lpl Financial LLC Gilead Sciences, Inc. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 1,058,542 shares of GILD stock, worth $93.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,058,542

Previous 1,038,356 1.94%

Holding current value

$93.2 Million

Previous $76.1 Million 4.51%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$63.15 - $72.88 $1.27 Million - $1.47 Million	20,186 Added 1.94%	1,058,542 $72.6 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $11.3 Million - $13.8 Million	158,023 Added 17.95%	1,038,356 $76.1 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.81 Million - $2.06 Million	24,748 Added 2.89%	880,333 $71.3 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $3.52 Million - $3.84 Million	47,547 Added 5.88%	855,585 $64.1 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $7.55 Million - $8.61 Million	-99,354 Reduced 10.95%	808,038 $62.3 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $20.5 Million - $23.4 Million	-265,790 Reduced 22.66%	907,392 $75.3 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $3.45 Million - $4.96 Million	55,385 Added 4.95%	1,173,182 $101 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $6.83 Million - $7.81 Million	114,767 Added 11.44%	1,117,797 $69 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $10.9 Million - $12.2 Million	188,351 Added 23.12%	1,003,030 $62 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2.71 Million - $3.4 Million	46,842 Added 6.1%	814,679 $48.4 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $3.57 Million - $4.05 Million	54,957 Added 7.71%	767,837 $55.8 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $4.64 Million - $5.01 Million	68,556 Added 10.64%	712,880 $49.8 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $2.11 Million - $2.31 Million	33,283 Added 5.45%	644,324 $44.4 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $520,860 - $594,301	8,681 Added 1.44%	611,041 $39.5 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $3.34 Million - $3.8 Million	58,886 Added 10.84%	602,360 $35.1 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $6.07 Million - $7.63 Million	97,776 Added 21.94%	543,474 $34.3 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $8.29 Million - $9.62 Million	-114,582 Reduced 20.45%	445,698 $34.3 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $7.93 Million - $10.2 Million	126,556 Added 29.18%	560,280 $41.9 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $245,432 - $269,967	3,983 Added 0.93%	433,724 $28.2 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $11.7 Million - $12.9 Million	186,870 Added 76.94%	429,741 $27.2 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $114,397 - $128,283	1,849 Added 0.77%	242,871 $16.4 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $937,574 - $1.05 Million	-14,994 Reduced 5.86%	241,022 $15.7 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $1.39 Million - $1.82 Million	-23,013 Reduced 8.25%	256,016 $16 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $525,618 - $581,956	-7,374 Reduced 2.57%	279,029 $21.5 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $2.11 Million - $2.46 Million	-32,494 Reduced 10.19%	286,403 $20.3 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $925,796 - $1.13 Million	-12,710 Reduced 3.83%	318,897 $24 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2.48 Million - $2.91 Million	34,823 Added 11.73%	331,607 $23.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $178,977 - $212,136	2,482 Added 0.84%	296,784 $24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	294,302	294,302 $20.8 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Gilead Sciences, Inc. Transaction History